NCT05739864View on ClinicalTrials.gov

Superdonor FMT in Patients With Ulcerative Colitis

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

February 13, 2023

Primary Completion Date

February 14, 2026

Study Completion Date

February 14, 2026

Conditions
Active Ulcerative Colitis
Interventions
BIOLOGICAL

FMT

This intervention is represented by the administration, in the recipients' gut, of super - donor microbiota through FMT

OTHER

Placebo FMT

This intervention is represented by the administration, in the recipients' gut, of a placebo through FMT

Trial Locations (1)

00168

RECRUITING

Gianluca Ianiro, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER